Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
201518603
Phase 1 mab active
Quick answer
Meningococcal ACYW135 Polysaccharide Conjugate Vaccine for Meningitis, Meningococcal is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Meningitis, Meningococcal
- Phase
- Phase 1
- Modality
- mab
- Status
- active